Ilaria C. Casetti
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Germline MPL mutations may be a rare cause of "triple-negative" thrombocytosis.
Journal: Experimental hematology
Published: September 16, 2023
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms.
Journal: Research and practice in thrombosis and haemostasis
Published: October 20, 2022
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Journal: Blood
Published: April 28, 2022
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms.
Journal: EJHaem
Published: March 11, 2022
Isolated congenital asplenia: An overlooked cause of thrombocytosis.
Journal: American journal of hematology
Published: February 06, 2022
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms.
Journal: Blood
Published: November 18, 2021
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.
Journal: Blood cancer discovery
Published: August 13, 2021
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis.
Journal: Hematological oncology
Published: July 28, 2021
The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance.
Journal: International journal of molecular sciences
Published: November 04, 2020
Last Updated: 09/26/2026